Italian guidelines for age range and test interval in breast cancer screening programmes: GRADE-ADOLOPMENT of the European guidelines.
ADOLOPMENT
Breast neoplasms
Europe
GRADE approach
Italy
Mass screening
Journal
La Radiologia medica
ISSN: 1826-6983
Titre abrégé: Radiol Med
Pays: Italy
ID NLM: 0177625
Informations de publication
Date de publication:
26 Oct 2024
26 Oct 2024
Historique:
received:
20
05
2024
accepted:
05
10
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
26
10
2024
Statut:
aheadofprint
Résumé
A guideline panel formulated a set of recommendations for breast cancer screening and diagnosis to implement clinical activities in Italy in alignment with the European Breast Cancer Guidelines on Screening and Diagnosis (European Commission Initiative on Breast Cancer-ECIBC). The panel issued national recommendations through adopting, adapting, and/or developing recommendations from the European guidelines (ADOLOPMENT approach). This process utilizes the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evidence to decision (EtD) framework. An additional PubMed search was conducted using search terms specific to Italy to tailor the EU guidelines to the national context. Nine articles were included as contextual evidence in the EtD. A total of 13 recommendations were finalized, either adapted or adopted to suit the national context. Organized breast cancer screening is strongly recommended for women aged 50-69 every 2 years, and it is conditionally recommended every 3 years for women aged 70-74, as well as every 1 or 2 years for women aged 45-49. Annual mammography received a strong recommendation against for women aged 50 and older. Developing shared national guidelines for the management of mammography screening will improve the standardization of processes across all settings, thereby promoting health equity.
Identifiants
pubmed: 39460891
doi: 10.1007/s11547-024-01900-0
pii: 10.1007/s11547-024-01900-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Investigateurs
Vittorio Cannatà
(V)
Isabella Castellano
(I)
Gabriella Dardanoni
(G)
Giulio Francolini
(G)
Stefania Gori
(S)
Carlo Magliocca
(C)
Stefania Montemezzi
(S)
Stefano Pacifici
(S)
Emanuele Torri
(E)
Annalisa Trianni
(A)
Daniela Ambrogetti
(D)
Catia Angiolini
(C)
Paola Bellardini
(P)
Adriana Bonifacino
(A)
Laura Bonvicini
(L)
Beniamino Brancato
(B)
Lauro Bucchi
(L)
Massimo Calabrese
(M)
Stefano Campa
(S)
Eva Carnesciali
(E)
Francesca Caumo
(F)
Silvia Deandrea
(S)
Flori Degrassi
(F)
Valeria Fava
(V)
Livia Giordano
(L)
Paolo Giorgi Rossi
(PG)
Paola Golinelli
(P)
Icro Meattini
(I)
Marco Moschetta
(M)
Paola Mosconi
(P)
Eugenio Paci
(E)
Loredana Pau
(L)
Stella Pedilarco
(S)
Francesca Pietribiasi
(F)
Marco Rosselli Del Turco
(M)
Marzia Salgarello
(M)
Gioele Santucci
(G)
Priscilla Sassoli de Bianchi
(P)
Roberto Satolli
(R)
Cristian Scatena
(C)
Carlo Senore
(C)
Margherita Serra
(M)
Mario Taffurelli
(M)
Marco Zappa
(M)
Pierpaolo Pattacini
(P)
Nereo Segnan
(N)
Informations de copyright
© 2024. Italian Society of Medical Radiology.
Références
Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. https://doi.org/10.3322/caac.21834
doi: 10.3322/caac.21834
pubmed: 38572751
ECIS—European Cancer Information System: European Commission. https://ecis.jrc.ec.europa.eu/ . Accessed September 1, 2019
Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet (London, England) 380(9855):1778–1786. https://doi.org/10.1016/S0140-6736(12)61611-0
doi: 10.1016/S0140-6736(12)61611-0
Ponti, A., Anttila, A., Ronco, G., et al. (2017). Cancer Screening in the European Union: Report on the implementation of the Council Recommendation on cancer screening. International Agency for Research on Cancer. https://health.ec.europa.eu/system/files/2017-05/2017_cancerscreening_2ndreportimplementation_en_0.pdf . Accessed January 25, 2024.
Battisti F, Mantellini P, Falini P et al (2022) Key performance indicators of breast cancer screening programmes in Italy, 2011–2019. Annali dell’Istituto superiore di sanita 58(4):244–253. https://doi.org/10.4415/ANN_22_04_04
doi: 10.4415/ANN_22_04_04
pubmed: 36511195
The Italian National Centre for Screening Monitoring (ONS) (2022). 2020 report. https://www.osservatorionazionalescreening.it/sites/default/files/allegati/Rapporto%20ONS%202020.pdf . Accessed January 25, 2024.
Schünemann HJ, Lerda D, Quinn C et al (2020) Breast cancer screening and diagnosis: a synopsis of the European breast guidelines. Ann Intern Med 172(1):46–56. https://doi.org/10.7326/M19-2125
doi: 10.7326/M19-2125
pubmed: 31766052
Castellini G, Bargeri S, Coclite D et al (2022) Knowledge, attitude and barriers of the Italian National Guidelines System for the development of clinical practice guidelines: a cross-sectional survey of registered scientific-technical societies. Annali dell’Istituto Superiore di Sanita 58(4):269–276. https://doi.org/10.4415/ANN_22_04_07
doi: 10.4415/ANN_22_04_07
pubmed: 36511198
Kahale LA, Ouertatani H, Brahem AB et al (2021) Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening. Health Res Policy Syst 19(1):80. https://doi.org/10.1186/s12961-021-00731-z
doi: 10.1186/s12961-021-00731-z
pubmed: 33985535
pmcid: 8117583
European Commission Initiative on Breast Cancer. European guidelines on breast cancer screening and diagnosis. https://cancer-screening-and-care.jrc.ec.europa.eu/en/ecibc/european-breast-cancer-guidelines . Accessed 23 Apr 2024.
Guyatt G, Oxman AD, Akl EA et al (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64(4):383–394. https://doi.org/10.1016/j.jclinepi.2010.04.026
doi: 10.1016/j.jclinepi.2010.04.026
pubmed: 21195583
Klugar M, Lotfi T, Darzi AJ et al (2024) GRADE guidance 39: using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses. J Clin Epidemiol 174:111494. https://doi.org/10.1016/j.jclinepi.2024.111494
doi: 10.1016/j.jclinepi.2024.111494
pubmed: 39117011
COUNCIL RECOMMENDATION of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening replacing Council Recommendation 2003/878/EC ( https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.C_.2022.473.01.0001.01.ENG ). Accessed 25 Jan 2024.
Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust. Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, editors. Washington (DC): National Academies Press (US); 2011
Brouwers MC, Kho ME, Browman GP et al (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 182(18):E839–E842. https://doi.org/10.1503/cmaj.090449
doi: 10.1503/cmaj.090449
pubmed: 20603348
pmcid: 3001530
Italian National Institute of Health. National Guideline System: oncological area. https://www.iss.it/-/lg-int-areaoncologica . Accessed 22 Jul 2024.
Okely AD, Ghersi D, Loughran SP et al (2022) A collaborative approach to adopting/adapting guidelines. The Australian 24-hour movement guidelines for children (5–12 years) and young people (13–17 years): an integration of physical activity, sedentary behaviour, and sleep. Int J Behav Nutr Phys Act 19(1):2. https://doi.org/10.1186/s12966-021-01236-2
doi: 10.1186/s12966-021-01236-2
pubmed: 34991606
pmcid: 8734238
Schünemann HJ, Al-Ansary LA, Forland F et al (2015) Guidelines international network: principles for disclosure of interests and management of conflicts in guidelines. Ann Intern Med 163(7):548–553. https://doi.org/10.7326/M14-1885
doi: 10.7326/M14-1885
pubmed: 26436619
Distante V, Frigerio A, Naldoni C, et al. (2006). On the opportunity of extending service screening by mammography to women of 40–49 and 70–74 years of age – Recommendations of a national Italian Consensus Conference. https://www.gisma.it/wp-content/uploads/2022/04/consensus_document.pdf . Accessed 25 Jan 2024.
Gini A, van Ravesteyn NT, Jansen EEL et al (2021) The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe. Prevent Med Rep 22:101392. https://doi.org/10.1016/j.pmedr.2021.101392
doi: 10.1016/j.pmedr.2021.101392